Genegrow
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 4
About Genegrow
Established in 2023 and based in Hangzhou, China, Genegrow was founded to advance synthetic biology applications in nutrition and health. Its core offerings include mass-produced astaxanthin, an antioxidant, and L-arginine, an amino acid used in supplements and pharmaceuticals. The company has built an integrated model from R&D to commercialization and distributes products mainly in China, with plans for international expansion., which supports the business through feed and food additives. Genegrow develops and manufactures synthetic biology products including astaxanthin, L-arginine, natural pigments, pharmaceutical intermediates, cosmetic ingredients and pesticide intermediates. Its products target industries such as dietary supplements, pharmaceuticals, cosmetics and agriculture. The company generates revenue primarily through B2B sales of synthetic biology-derived products to health supplement, pharmaceutical, and cosmetic companies. Revenue is supported by bulk sales contracts for key products such as astaxanthin and L-arginine, ect.
Who invested in Genegrow
4 investors across 1 round
See all investors in Genegrow
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 5, 2025
Amount
Undisclosed
Investors
Questions about Genegrow
Who invested in Genegrow?
Genegrow has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genegrow raised?
Genegrow has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Genegrow last raise money?
Genegrow's most recent round on record is a Series A, in Sep 2025.
What does Genegrow do?
Established in 2023 and based in Hangzhou, China, Genegrow was founded to advance synthetic biology applications in nutrition and health.
Where is Genegrow headquartered?
Genegrow is headquartered in Hangzhou, China.
Which VCs invest in companies like Genegrow?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genegrow's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Genegrow? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.